somatrem

Known as: somatrem [Chemical/Ingredient], Somatrem (genetical recombination), growth hormone, human methionyl 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-2013
0519862013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
To identify factors influencing the response to GH therapy, we used a multiple regression model to analyze data from 632 naive… (More)
Is this relevant?
1988
1988
Five male children with chronic renal failure (CRF) and growth retardation were treated with recombinant human GH (somatrem… (More)
Is this relevant?
1988
1988
This report extends to 3 years the prospective study of the effects of somatrem alone or in combination with oxandrolone on… (More)
Is this relevant?
1988
1988
During 1985-86 a multricentric trial to evaluate the safety and efficacy of Somatrem (SomatonormR) in children with growth… (More)
Is this relevant?
1987
1987
In a multicentre clinical trial 54 children aged 4.0 to 17.3 years, who had growth hormone deficiency that had not previously… (More)
  • table I
  • table 2
Is this relevant?
1987
1987
The effects of a 12-week period of substitution therapy with somatrem have been investigated in six adults with confirmed hGH… (More)
Is this relevant?
1986
1986
A total of 62 patients with pituitary dwarfism were treated with three different preparations of human growth hormone (hGH… (More)
Is this relevant?
1986
1986
A total of 63 patients with hGH deficiency were recruited, of whom 59 are evaluable. Somatrem (Somatonorm), 4 IU three times/week… (More)
Is this relevant?
1986
1986
  • H. Flodh
  • Acta paediatrica Scandinavica. Supplement
  • 1986
The molecular basis of recombinant DNA technology is described, and the principles of genetically engineered proteins developed… (More)
Is this relevant?
1986
1986
A total of 21 patients with Turner's syndrome were treated with pituitary hGH and/or somatrem for 1-2 years. Plasma non… (More)
Is this relevant?